They found that using the VASH collimator with an existing
breast molecular imaging system, they could get six times better contrast of tumors in the breast, which could potentially reduce the radiation dose to the patient by half from the current levels, while maintaining the same or better image quality.
Adding this variable angle slant hole collimator to an existing
breast molecular imaging system allows the system to get six times better contrast of cancer lesions in the breast, providing the same or better image quality while also potentially reducing the radiation dose to the patient by half.
Not exact matches
Medical devices range from the simple, such as Band - Aids, to the high - tech, such as
imaging machines and the BRCA1 and BRCA2
molecular diagnostic tests for
breast cancer (see sidebar).
«Our findings demonstrate the feasibility of classifying cancerous and normal
breast tissues using DESI mass spectrometry
imaging,» said Nathalie Agar, PhD, director of the Surgical Molecular Imaging Laboratory, BWH Departments of Neurosurgery and Radiology, senior study
imaging,» said Nathalie Agar, PhD, director of the Surgical
Molecular Imaging Laboratory, BWH Departments of Neurosurgery and Radiology, senior study
Imaging Laboratory, BWH Departments of Neurosurgery and Radiology, senior study author.
Molecular Breast Imaging (MBI) is a supplemental imaging technology designed to find tumors that would otherwise be obscured by surrounding dense breast tissue on a mamm
Breast Imaging (MBI) is a supplemental imaging technology designed to find tumors that would otherwise be obscured by surrounding dense breast tissue on a mam
Imaging (MBI) is a supplemental
imaging technology designed to find tumors that would otherwise be obscured by surrounding dense breast tissue on a mam
imaging technology designed to find tumors that would otherwise be obscured by surrounding dense
breast tissue on a mamm
breast tissue on a mammogram.
«Combined optical and
molecular imaging could guide
breast - conserving surgery.»
Now, researchers are hoping to improve this
imaging technique, known as
molecular breast imaging or
breast specific gamma
imaging, with better image quality and precise location (depth information) within the
breast, while reducing the amount of radiation dose to the patient for these procedures.
Paulsen's study investigated whether the addition of
molecular imaging (NIRST) at the time of MRI would improve the diagnostic accuracy of
breast MRI alone by contributing functional information about regions of suspicion in the
breast identified by the MRI and helping to categorize the regions as malignant or benign.
Current
molecular breast imaging systems use a traditional collimator, which is essentially a rectangular plate of dense metal with a grid of holes, to «filter» the gamma rays for the camera.
For years researchers have been developing
molecular imaging techniques that visualize hormonally active
breast cancer cells — specifically those testing positive for human epidermal growth factor receptor 2 (HER2).
«
Molecular imaging finds novel way to knock down
breast cancer.»
A recent innovation in
breast cancer biomarkers seeks the HER3 receptor instead, which could mean more comprehensive
breast cancer
imaging and potential treatments, say experts presenting data during the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual M
imaging and potential treatments, say experts presenting data during the Society of Nuclear Medicine and
Molecular Imaging's 2014 Annual M
Imaging's 2014 Annual Meeting.
«Metastatic brain tumors — often from lung,
breast or skin cancers — are the most commonly observed tumors within the brain and account for about 30 percent of advanced
breast cancer metastases,» says Khalid Shah, MS, PhD, director of the
Molecular Neurotherapy and
Imaging Laboratory in the MGH Departments of Radiology and Neurology, who led the study.
Projects within our program emphasize
molecular imaging of cancer, and notably
imaging - based assessment of response to anti-cancer pharmaceuticals in colorectal and
breast cancer.
Chanda N, Shukla R, Katti KV, Kannan R. Gastrin releasing protein receptor specific gold nanorods:
breast and prostate tumor avid nanovectors for
molecular imaging.